Neumora Therapeutics Inc <NMRA.O>: RBC cuts target price to $5 from $7
NMRA•Related News
TransDigm withdraws from proposed acquisition of Stellant Systems
TDG•
Mayville Engineering Co <MEC.N>: Citigroup raises target price to $43 from $33
MEC•
Pershing Square Inc <PS.N>: Citigroup cuts target price to $45 from $50
PS•
Deere & Co <DE.N>: Citigroup raises target price to $610 from $575
DE•
Namib Minerals director Wendy Luhabe files initial beneficial ownership statement
NAMM•